SSBP1 and glioblastoma: This result implied that the strategy of combining an SSBP1 inhibitor with TMZ would benefit tumour treatment by enhancing TMZ sensitivity, however, additional efforts are required to translate this strategy into the clinical setting to benefit GBM patients.